Quantifying Ligand-Protein Binding Kinetics with Self-Assembled Nano-oscillators
- PMID: 31593433
- PMCID: PMC6995402
- DOI: 10.1021/acs.analchem.9b04195
Quantifying Ligand-Protein Binding Kinetics with Self-Assembled Nano-oscillators
Abstract
Measuring ligand-protein interactions is critical for unveiling molecular-scale biological processes in living systems and for screening drugs. Various detection technologies have been developed, but quantifying the binding kinetics of small molecules to the proteins remains challenging because the sensitivities of the mainstream technologies decrease with the size of the ligand. Here, we report a method to measure and quantify the binding kinetics of both large and small molecules with self-assembled nano-oscillators, each consisting of a nanoparticle tethered to a surface via long polymer molecules. By applying an oscillating electric field normal to the surface, the nanoparticle oscillates, and the oscillation amplitude is proportional to the number of charges on the nano-oscillator. Upon the binding of ligands onto the nano-oscillator, the oscillation amplitude will change. Using a plasmonic imaging approach, the oscillation amplitude is measured with subnanometer precision, allowing us to accurately quantify the binding kinetics of ligands, including small molecules, to their protein receptors. This work demonstrates the capability of nano-oscillators as an useful tool for measuring the binding kinetics of both large and small molecules.
Conflict of interest statement
Conflict of Interest Statement
NJT is a co-founder of Biosensing Instrument Inc and grant R44GM126720 was funded via Biosensing instrument Inc.
Figures
References
-
- Okada-Iwabu M; Yamauchi T; Iwabu M; Honma T; Hamagami K.-i.; Matsuda K; Yamaguchi M; Tanabe H; Kimura-Someya T; Shirouzu M; Ogata H; Tokuyama K; Ueki K; Nagano T; Tanaka A; Yokoyama S; Kadowaki T, A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 2013, 503 (7477), 493–499. - PubMed
-
- Sharpe HJ; Wang W; Hannoush RN; de Sauvage FJ, Regulation of the oncoprotein Smoothened by small molecules. Nat Chem Biol 2015, 11 (4), 246–255. - PubMed
-
- Zimmermann G; Papke B; Ismail S; Vartak N; Chandra A; Hoffmann M; Hahn SA; Triola G; Wittinghofer A; Bastiaens PIH; Waldmann H, Small molecule inhibition of the KRAS-PDE[dgr] interaction impairs oncogenic KRAS signalling. Nature 2013, 497 (7451), 638–642. - PubMed
-
- Mistry P; Laird MHW; Schwarz RS; Greene S; Dyson T; Snyder GA; Xiao TS; Chauhan J; Fletcher S; Toshchakov VY; MacKerell AD; Vogel SN, Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain. Proceedings of the National Academy of Sciences 2015, 112 (17), 5455–5460. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
